262 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
251 | 10215647 | Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. | 1999 May | 2 |
252 | 10377455 | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. | 1999 Jun 22 | 1 |
253 | 10383505 | Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. | 1999 Jun | 1 |
254 | 10391112 | Clinical experience with cyclooxygenase-2 inhibitors. | 1999 May | 1 |
255 | 10391671 | Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. | 1999 Jun | 2 |
256 | 10406640 | The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. | 1999 Jul 5 | 3 |
257 | 10411562 | Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. | 1999 Aug | 7 |
258 | 10414247 | [Specific inhibitors of cyclo-oxygenase-2: a revolution?]. | 1999 Jun 19 | 1 |
259 | 10500058 | A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. | 1999 Oct | 1 |
260 | 10566565 | The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. | 1999 Oct | 1 |
261 | 10580458 | Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. | 1999 Nov 24 | 1 |
262 | 10692773 | Novel nonsteroidal anti-inflammatory drugs. | 1999 Oct-Dec | 1 |